Waiving patent rights may have chilling effect on medicine development, industry warns
Oliver O Connor
Industry says waiver of IP rights not needed as vaccine supply far outweighs demand
Just half of 41 cancer drugs approved from 2017-2020 were available here at end of 2021
Medicines regularly not worth approving at asking price
Upfront costs high but treatments may cut long-term expense and boost patient results
Two Ministers back US support for patent waiver opposed by pharmaceutical industry
New medicines have cut number of years of life lost to heart disease by 34% since 2005
Major drug manufacturers already at full capacity producing other medications